Next Article in Journal
Recent Advances in Volatiles of Teas
Next Article in Special Issue
Nanotechnology-Based Drug Delivery Systems for Photodynamic Therapy of Cancer: A Review
Previous Article in Journal
Chitosan Nanoparticles as Carriers for the Delivery of ΦKAZ14 Bacteriophage for Oral Biological Control of Colibacillosis in Chickens
Previous Article in Special Issue
Novel Gold Nanoparticles Reduced by Sargassum glaucescens: Preparation, Characterization and Anticancer Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Synthesis, Characterization and in Vitro Evaluation of Manganese Ferrite (MnFe2O4) Nanoparticles for Their Biocompatibility with Murine Breast Cancer Cells (4T1)

by
Samikannu Kanagesan
1,*,
Sidek Bin Ab Aziz
1,2,
Mansor Hashim
1,
Ismayadi Ismail
1,
Subramani Tamilselvan
3,
Noorjahan Banu Binti Mohammed Alitheen
3,
Mallappa Kumara Swamy
3,4 and
Bandaru Purna Chandra Rao
5
1
Materials Synthesis and Characterization Laboratory (MSCL), Institute of Advanced Technology (ITMA), Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia
2
Department of Physics, Faculty of Science, Universiti Putra Malaysia, UPM Serdang 43400, Selangor, Malaysia
3
Department of Cell and Molecular Biology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia
4
Department of Crop Science, Universiti Putra Malaysia (UPM), Serdang 43400, Selangor, Malaysia
5
Department of Applied Science and Humanities, Sasi Intitute of Technology and Engineering, Tadepalligudem, West Godavari District 534101, Andhra Pradesh, India
*
Author to whom correspondence should be addressed.
Molecules 2016, 21(3), 312; https://doi.org/10.3390/molecules21030312
Submission received: 24 December 2015 / Revised: 23 February 2016 / Accepted: 24 February 2016 / Published: 11 March 2016
(This article belongs to the Special Issue Pharmaceutical Nanotechnology: Novel Approaches)

Abstract

:
Manganese ferrite (MnFe2O4) magnetic nanoparticles were successfully prepared by a sol-gel self-combustion technique using iron nitrate and manganese nitrate, followed by calcination at 150 °C for 24 h. Calcined sample was systematically characterized by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), and vibrational sample magnetometry (VSM) in order to identify the crystalline phase, functional group, morphology, particle size, shape and magnetic behavior. It was observed that the resultant spinal ferrites obtained at low temperature exhibit single phase, nanoparticle size and good magnetic behavior. The study results have revealed the existence of a potent dose dependent cytotoxic effect of MnFe2O4 nanoparticles against 4T1 cell lines at varying concentrations with IC50 values of 210, 198 and 171 μg/mL after 24 h, 48 h and 72 h of incubation, respectively. Cells exposed to higher concentrations of nanoparticles showed a progressive increase of apoptotic and necrotic activity. Below 125 μg/mL concentration the nanoparticles were biocompatible with 4T1 cells.

1. Introduction

Nowadays, research on magnetic ferrite nanoparticles has become of great interest due to their extraordinary magnetic properties and they have been used technologically in permanent magnets, ferrofluids, broad band transformers, magnetic sensors, etc. Special attraction has also been paid to biomedical applications like drug delivery, biosensors, magnetic resonance imaging and magnetic hydrothermia [1,2,3,4,5,6,7]. Manganese ferrite nanoparticles exhibit superior mechanical, luminescent and magnetic properties compared to other existing magnetic ferrite nanoparticles. In recent times, manganese ferrite nanoparticles synthesized by traditional ceramic methods [8,9,10] suffered from drawbacks like uncontrolled particle size, uniformity, poorly defined stoichiometric composition, the presence of impurities during ball milling, chemical inhomogeneity, contamination, and high calcination temperatures [11,12]. Many preparation methods have been used across the globe in the process of synthesis of these magnetic nanoparticles, include sol-gel [13,14], flash combustion [15] citrate gel [16], co-precipitation [17,18], hydrothermal synthesis [19], sol-gel auto combustion [20], micro-emulsion [21] and low temperature combustion methods [22]. It was reported that the chemical routes are the most suitable to synthesize nanomagnetic particles, among them, the sol-gel self-combustion method has attracted considerable attention and said to be a flexible method to synthesize spinel MnFe2O4 nanoparticles. Researchers [19,20,21,23] have dedicated their efforts to the synthesis and study of spinel ferrites due to the special properties they exhibit in the nano range.
In recent years, various types of nanoparticles synthesized from inorganic as well as organic materials have shown potential applications in cancer therapy [24,25]. Magnetic nanoparticles used as drug delivery structures appear very beneficial as they show remarkable heating effects and thus provide an opportunity to target tumor cells specifically [26,27]. Most of the drugs used for treating cancer exhibits toxicity to both tumor and normal cells, causing side effects and this restricts the effectiveness of chemotherapy treatments. Therefore, understanding these nanoparticles and their toxicity is very important. In the past, though few researchers have studied the cytotoxic effects of different magnetic nanoparticles, their studies are restricted to only few magnetic nanoparticles [26,28,29]. Previously, a study by [28] showed that MnFe2O4nanoparticles of size 40nm were efficiently internalized by PC-12 cells, which suggest the possible use of these nanoparticles as an anticancer drug. However, there is a need to screen these nanoparticles before clinically used for cancer therapy. Therefore, this study was aimed at characterizing the structural, morphological, magnetic properties of MnFe2O4 nanoparticles synthesized by sol-gel self-combustion technique. Also, MnFe2O4 nanoparticles were evaluated for their cytotoxicity against 4T1 murine breast cancer cell lines.

2. Results and Discussion

2.1. Fourier Transform Infrared Spectroscopy

Figure 1 shows the FTIR spectrum of the calcined MnFe2O4 magnetic nanoparticles in the range between 500 and 4000 cm−1.
A broad band absorption peak appeared at 3412 cm−1 and a high frequency absorption peak was detected at 1718 cm−1, confirming the presence of O-H groups in the sample. The characteristic band at 1382 cm−1 is related to the symmetric vibrations of the NO3 group [30]. Generally, the metal oxide vibrations occur below 1000 cm−1. The peaks appearing below 700 cm−1 are due to the spinel structure. The band around 539 cm−1 is attributed to the intrinsic vibrations of octahedral coordinated metal ions in the spinel structure, confirming that the prepared samples are spinel in structure [30].

2.2. XRD Analysis

The X-ray diffraction pattern of a MnFe2O4 calcined sample is illustrated in Figure 2. All diffraction peak positions and relative intensities correspond to the Fd3m space group with a cubic structure which exactly coincides with the standard spinel manganese ferrite (JCPDS card no. 74-2403). The average crystallite size of MnFe2O4 was calculated by considering the full width at half-maximum (FWHM) of diffraction based on the Scherrer’s formula:
D = ( 0.9 λ ) β cos ( θ )
where D is the average particle size of the crystallites, λ is the incident wavelength, θ is the Bragg angle and β is the diffracted full width at half maximum (in radians) caused by crystallation. The average crystallite size of the resulting nanoparticles was 32 nm. It is interesting to note that spinel ferrite diffraction peaks were quite broad due to the small particle size.

2.3. Morphological Analysis

The preparation process was clearly demonstrated to have a considerable influence on the morphologies of the resulting spinel ferrites.
The size, shape, and morphologies of the low-temperature synthesized MnFe2O4 nanoparticles were further determined by TEM. The TEM images (Figure 3) show that the majority of the particles are almost spherical in shape and agglomerated. The average particle size varied in the 25–35 nm range. The average particle size obtained from TEM is thus in good agreement with that determined from the Scherrer formula.

2.4. Magnetic Analysis

Figure 4 presents the hysteresis loop of the calcined MnFe2O4 sample measured in a magnetic field by a vibrating sample magnetometer. The calcined MnFe2O4 powder exhibits ferromagnetic behavior with saturation magnetization (Ms), coercivity (Hc) and remanent magnetization (Mr), values of about 85 Am2/kg, 148.7 Oe, and 16.68 Am2/kg, respectively, and these values are varied from reported hydrothermally synthesized MnFe2O4 (Ms = 78.3 Am2/kg, Mr = 5.32Am2/kg, Hc = 45 Oe) [31] and the sample prepared by combustion route (Ms = 80 Am2/kg, Mr = 50Am2/kg, Hc = 85Oe) [32]. Generally, magnetic properties vary with the variations in the particle size, shape, crystallinity etc. The saturation magnetization value is almost equal to the reported bulk MnFe2O4 (73.8 Am2/kg, 80 Am2/kg) [31,32].

2.5. Cytotoxicity Analysis

The cytotoxicity of MnFe2O4 nanoparticles synthesized by the sol-gel salt combustion technique was evaluated against a murine breast cancer cell line (4T1) using the MTT assay.
The results of our study revealed the existence of a potent toxicity effect of MnFe2O4 nanoparticles against 4T1 cell lines at varying concentrations (Figure 5). The cell viability percentage was observed to decrease with increased concentration of MnFe2O4 nanoparticles indicating a dose dependent cytotoxic effect. With the increase of exposure time from 24 h to 72 h, the cell viability percentage was further reduced, irrespective of the concentration tested. After 24 h of incubation, control treatments showed the highest cell viability percentage (100%) while the lowest (11%) was observed at 320 μg/mL nanoparticle concentration after 72 h. IC50 values of 210 μg/mL, 198 μg/mL and 171 μg/mL were observed after 24, 48 and 72 h of incubation, respectively. Similarly, it has been reported that Mn nanoparticles induce time and dose dependent cytotoxic activity against N27 dopaminergic neuronal cells [33]. Further confirmation of the cell toxicity effect due to MnFe2O4 nanoparticles involving apoptotic changes and condensation of nuclei was studied using the AO/PI staining method. All viable and early apoptotic cells are stained by AO and generate green fluorescence, while necrotic and dead cells stained by PI produce red fluorescence. Our study revealed that increased exposure to MnFe2O4 nanoparticles concentrations over all incubation periods resulted in decreased cell viability in comparison to control cells (Figure 6).
When the cells were exposed to higher concentrations of nanoparticles they showed a progressive increase of apoptotic and necrotic activity. However, at 500 μg/mL 100% cytotoxicity with higher necrotic cells was observed after 48 h and 72 h of incubation. The results showed 36% of apoptotic cells and 64% of necrotic cells after 48h of treatment at 500 μg/mL while, at the same concentration 30% of apoptotic cells and 70% necrotic cells were observed after 72 h. This clearly suggests that higher concentrations of MnFe2O4 nanoparticles cause more necrotic activity than apoptosis. The induction of apoptotic cellular death observed in 4T1 cell lines was further quantified by using flow cytometry after staining the cells with green fluorescent FITC labeled Annexin V dye because of its sensitivity [34]. In this method, annexin V attached to the externalized residues of phosphatidylserine occurring on the cell membrane of apoptotic cells at their early stage are visualized using fluorescence microscopy [24,35]. Flow cytometric data of 4T1 cell lines treated with MnFe2O4 nanoparticles stained with annexin V-FITC/propidium iodide are shown in the Figure 7. The results clearly indicate the dose dependent activity of cell toxicity with 100% cell death observed at 500 μg/mL concentration under all incubation period while, apoptotic and necrotic cell population increased with higher concentrations of nanoparticles treatments. The cells treated at 500 μg/mL concentration for 24, 48 and 72 h showed 25%, 30% and 28% of apoptosis, respectively. Conversely, at 500 μg/mL concentration for 24, 48 and 72 h showed 75%, 70% and 72% of necrotic activity, respectively. Similarly, dose dependent cytotoxicity with increased apoptotic and necrotic cells were observed in 4T1 cells when treated with copper ferrite nanoparticles [23].
Previous studies have documented that metal nanoparticles produce cellular damage and apoptosis due to induced oxidative stress, inflammatory responses triggered by reactive oxygen species and increased levels of TNF-α. According to Park et al. [36], the cytotoxicity is attributable to the ionization of metallic nanoparticles in cells as expressed by a “Trojan-horse” type mechanism. Based on these reports it can be affirmed that MnFe2O4 nanoparticles after entering the cells release their ions and cause various cellular alterations/damages leading to cell death.
From the present study, it is observed that MnFe2O4 nanoparticles were efficient in inducing cytotoxicity against 4T1 cells with a dose dependent apoptotic and necrotic activity. However, higher concentrations were more detrimental to the cell survivability as they induced more necrosis. In humans, cell death due to apoptosis or necrosis is an important biological process and any abnormalities in cell death may result in various diseases including cancer. Thus, a better understanding of apoptosis and necrosis processes can be a target for treatment [37,38]. Presently, cytotoxic drugs are mostly targeted on inducing apoptosis in cancer cells, however resistance to apoptosis, apoptosis in normal cells associated with side effects leads to treatment failure. Despite continuing progress made in the discovery cytotoxic agents, there is a need to explore new key molecules [38]. In this regard, the results of our study are promising and there MnFe2O4 nanoparticles can serve as a potential cytotoxic agent for various targeted therapies including cancer treatment.

3. Experimental Section

3.1. Preparation of MnFe2O4 Nanoparticles

AR grade manganese nitrate, ferric nitrate and citric acid were purchased from Aldrich Chemicals (St. Louis, MO, USA). Manganese nitrate and ferric nitrate in the molar ratio of 1:2, and citric acid in the ratio of 1:1 with nitrates were dissolved in a minimum amount of ethanol. A suitable amount of oleic acid was added to the solution. The solution was stirred for 4 h at room temperature and concentrated in a vacuum rotary evaporator at 60–80 °C to remove surplus water. The gel was heated at 150 °C in a hot air oven for 24 h. A brown color MnFe2O4 powder was obtained.

3.2. Characterization

The X-ray diffraction patterns of the calcined powder sample was studied by a PAN Analytical (PANalytical B.V.Corporate Marketing and Communications Department Lelyweg 1, 7602 EA PO Box 13, 7600 AA, Almelo, The Netherlands) X’pert pro X-ray diffractometer with CuKa radiation at 45 kV, 40 mA (k = 0.15406 nm) and fixed 2θ is in the range of (20° ≤ 2θ ≤ 70°). The microstructure observation of the specimen was performed by transmission electron microscopy (JEM 3010-JEOL, Sollentuna, Sweden) with an accelerating voltage of 200 kV. The magnetic characteristics of the specimen were measured at room temperature using vibrating sample magnetometry (LakeShore 7407, Lake Shore Cryotronics, Inc., 575 McCorkle Blvd, Westerville, OH, USA).

3.3. Evaluation of Cytotoxicity Activity

We evaluated the cytotoxic effect of MnFe2O4 nanoparticles on the murine breast cancer cell line (4T1) as described previously by Swamy et al. [25]. Briefly, the cells were cultured on Dulbecco’s Modified Eagle’s Medium (DMEM) added with l-glutamine (2 mM), penicillin (100 U/mL), streptomycin (100 g/mL) and fetal bovine serum (10%). Approximately 5 × 104 cells were inoculated in each well of 96-well plates and incubated in a carbon dioxide incubator maintained at 37 °C for 48 h. For the cytotoxicity test, the cells were challenged with MnFe2O4 nanoparticles (0, 20, 40, 80, 160 and 320 µg/mL) and incubated for 24, 48 and 72 h separately to study cell viability using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. About 10 mL of MTT solution (5 mg/mL) was added to each well and further kept for 4 h of incubation under the same conditions and using a multi-well ELISA plate reader, absorbance was recorded at 570 nm. The absorbance was converted to percentage of cell viability by using the following formula:
%   o f   c e l l   v i a b i l i t y   = V a l u e   i n   t h e   e x p e r i m e n t a l   s a m p l e V a l u e   o f   o p t i c a l   d e n s i t y   i n   c o n t r o l   s a m p l e

3.4. Analysis of Apoptosis

3.4.1. Acridine Orange/Propidium Iodide (AO/PI) Double Staining

Murine breast cancer cells (4T1) were plated at 1 × 106 cells/well into 96-well plates and treated with various concentrations of MnFe2O4 nanoparticles (125, 250 and 500 µg/mL) for 24, 48 and 72 h independently. The cells were washed with PBS, fixed in methanol: acetic acid (3:1, v/v) for 10 min and stained with 10 μL of 10 mg/mL fluorescent dyes containing acridine orange (AO) and propidium iodide (PI) for 10 min. After washing the cells with phosphate buffer solution, stained cells were observed under FACS Calibur flow cytometry system (BD Biosciences, Franklin Lakes, NJ, USA).

2.4.2. Annexin V-PI Staining

Apoptosis induction was studied in MnFe2O4 nanoparticle-challenged murine breast cancer cells (4T1) using annexin V-PI staining. Briefly, about 1 × 106 cells/mL of murine breast cancer cells (4T1) were grown in 96-well plates and incubated for 24 h. Later, cells were challenged with different levels of MnFe2O4 nanoparticles (125, 250 and 500 µg/mL) and incubated for 24, 48 and 72 h. The cells were washed with phosphate buffer solution (1 mL) and centrifuged to get the cell pellet and later cells were added with binding buffer and stained with FITC-conjugated annexin V by following the manufacturer’s protocol (FITC Annexin V Apoptosis Detection Kit, BD Pharmingen, Franklin Lakes, NJ, USA). Using FACS Calibur flow cytometry system (BD Biosciences), the treated cells were visualized to record the data.

4. Conclusions

The sol-gel self-combustion method has been used for the successful preparation of manganese ferrite nanoparticles with an average particle size of about 30 nm. Face centered cubic MnFe2O4 nanoparticles were confirmed from the XRD result and was exactly matched with standard JCPDS data. The magnetic hysteresis properties such as saturation magnetization and coercivity at room temperatures were found to be 85 Am2/kg and 148 Gauss, respectively. MnFe2O4 nanoparticles exhibited dose dependent cytotoxic effects against 4T1 cells. Both apoptotic and necrotic activity were observed at all concentrations of MnFe2O4 nanoparticles tested. However, higher concentrations showed lesser cell survivability with increased necrosis. Our results suggest the possible exploration of MnFe2O4 nanoparticles as drug carrier agents in targeted cancer therapy.

Acknowledgments

We would like to thank Universiti Putra Malaysia for providing the Financial and Center Facilities.

Author Contributions

The experimental work was designed and performed by S.K under the supervision of S.A.B.A. S.T and M.K.S. contributed to the biological studies. M.H, N.B.A, I.I and S.A.B.A provided scientific guidance. S.K, B.P.C.R and M.K.S drafted the manuscript. All authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Mohapatra, M.; Anand, S. Synthesis and applications of nano-structured iron oxides/hydroxides—A review. Int. J. Eng. Sci. Technol. 2010, 2, 127–146. [Google Scholar] [CrossRef]
  2. Zak, T.; Cosovic, V.; Cosovic, A.; David, B.; Talijan, N.; Zivkovic, D. Formation of magnetic microstructure of the nanosized NiFe2O4 synthesized via solid-state reaction. Sci. Sinter. 2012, 44, 103–112. [Google Scholar] [CrossRef]
  3. Standley, K.J. Oxide Magnetic Materials, 2nd ed.; Clarendon Press: Oxford, UK, 1972. [Google Scholar]
  4. Yattinahalli, S.S.; Kapatkar, S.B.; Ayachit, N.H.; Mathad, S.N. Synthesis and structural characterization of nanosized nickel ferrite. Int. J. Self Propag. High Temp. Synth. 2013, 22, 147–150. [Google Scholar] [CrossRef]
  5. Safarik, I.; Horska, K.; Pospiskova, K.; Safarikova, M. Magnetic techniques for the detection and determination of xenobiotics and cells in water. Anal. Bioanal. Chem. 2012, 404, 1257–1273. [Google Scholar] [CrossRef] [PubMed]
  6. Pospiskova, K.; Safarik, I.; Sebela, M.; Kuncova, G. Magnetic particles-based biosensor for biogenic amines using an optical oxygen sensor as a transducer. Microchim. Acta 2013, 180, 311–318. [Google Scholar] [CrossRef]
  7. Xianjin, C.; Salome, B.; Dirk, K.Y.Y.; Rafael, T.M.; De, R.; Maite, J.-O.; Haitao, Y.; Shi, S.; Domokos, M.; Noemi, K.; et al. Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging. Biomaterials 2014, 35, 5840–5846. [Google Scholar]
  8. Singh, M.; Sud, S.P. Controlling the properties of magnesium–manganese ferrites. Mater. Sci. Eng. B 2001, 83, 180–184. [Google Scholar] [CrossRef]
  9. Lakshman, A.; Rao, K.H.; Mendiratta, R.G. Magnetic properties of In3+ and Cr3+ substituted Mg-Mn ferrites. J. Magn. Magn. Mater. 2002, 250, 92–97. [Google Scholar] [CrossRef]
  10. Ahmed, M.A.; El-Khawas, E.H.; Radwan, F.A. Dependence of dielectric behaviour of Mn-Zn ferrite on sintering temperature. J. Mater. Sci. 2001, 36, 5031–5035. [Google Scholar] [CrossRef]
  11. Deng, H.; Chen, H.; Li, H. Synthesis of crystalMFe2O4 (M = Mg, Cu, Ni) microspheres. Mater. Chem. Phys. 2007, 101, 509–513. [Google Scholar] [CrossRef]
  12. Yu, S.H.; Yoshimura, M. Direct fabrication of ferrite MFe2O4 (M = Zn, Mg)/Fe composite thin films by soft solution processing. Chem. Mater. 2000, 12, 3805–3810. [Google Scholar] [CrossRef]
  13. Qi, X.; Zhou, J.; Yue, Z.; Gui, Z.; Li, L. Permeability and microstructure of manganese modified lithium ferrite prepared by sol-gel auto-combustion method. J. Mater. Sci. Eng. B 2003, 99, 278–281. [Google Scholar] [CrossRef]
  14. Yan, S.; Ling, W.; Zhou, E. Rapid synthesis of Mn0.65Zn0.35Fe2O4/SiO2 homogeneous nanocomposites by modified sol-gel auto-combustion method. J. Cryst. Growth 2004, 273, 226–233. [Google Scholar] [CrossRef]
  15. Mangalaraja, R.V.; Anathakmar, S.; Manohar, P.; Gnanam, F.D.; Awana, M. Characterization of Mn0.8Zn0.2Fe2O4 synthesized by flash combustion technique. Mater. Sci. Eng. A 2004, 367, 301–305. [Google Scholar] [CrossRef]
  16. Sileo, E.E.; Jacobo, S.E. Gadolinium–Nickel ferrites prepared from metal citrates precursors. Phys. B Condensed Matter. 2004, 354, 241–245. [Google Scholar] [CrossRef]
  17. Bujoreanu, V.M.; Diamandescu, L.; Brezeanu, M. On the structure of manganese ferrite powder prepared by coprecipitation from MnO2 and FeSO4 center dot 7H(2)O. Mater. Lett. 2000, 46, 169–174. [Google Scholar] [CrossRef]
  18. Upadhyay, R.V.; Davies, K.J.; Wells, S.; Charles, S.W. Preparation and characterization of ultra-fine MnFe2O4 and MnxFe1-xFe2O4 spinel systems: I. particles. J. Magn. Magn. Mater. 1994, 132, 249–257. [Google Scholar] [CrossRef]
  19. Xiangyu, H.; Jing, F.; Xiaodong, X.; Milin, Z. Synthesis and characterizations of spinel MnFe2O4 nanorod by seed-hydrothermal route. J. Alloys Compd. 2010, 491, 258–263. [Google Scholar]
  20. Shanmugavela, T.; Gokul Rajb, S.; Ramesh Kumarc, G.; Rajarajana, G. Synthesis and Structural Analysis of Nanocrystalline MnFe2O4. Phys. Procedia 2014, 54, 159–163. [Google Scholar] [CrossRef]
  21. Zaki, T.; Saed, D.; Aman, D.; Younis, S.A.; Moustafa, Y.M. Synthesis and characterization of MFe2O4 sulfur nanoadsorbents. J. Sol-Gel Sci. Technol. 2013, 65, 269–276. [Google Scholar] [CrossRef]
  22. Kanagesan, S.; Hashim, M.; Tamilselvan, S.; Alitheen, N.B.; Ismail, I.; Hajalilou, A.; Ahsanul, K. Synthesis, Characterization, and Cytotoxicity of Iron Oxide Nanoparticles. Adv. Mater. Sci. Eng. 2013, 2013. [Google Scholar] [CrossRef]
  23. Kanagesan, S.; Hashim, M.; Tamilselvan, S.; Alitheen, N.B.; Ismail, I.; Syazwan, M.; ZuikimiI, M.M.M. Sol-Gel Auto-Combustion Synthesis of Cobalt Ferrite and it’s Cytotoxicity Properties. Dig. J. Nanomater. Biostruct. 2013, 8, 1601–1610. [Google Scholar]
  24. Akhtar, M.; Swamy, M.K.; Umar, A.; Sahli, A.; Abdullah, A. Biosynthesis and characterization of silver nanoparticles from methanol leaf extract of Cassia didymobotyra and assessment of their antioxidant and antibacterial activities. J. Nanosci. Nanotechnol. 2015, 15, 9818–9823. [Google Scholar] [CrossRef] [PubMed]
  25. Swamy, M.K.; Akhtar, M.S.; Mohanty, S.K.; Sinniah, U.R. Synthesis and characterization of silver nanoparticles using fruit extract of Momordica cymbalaria and assessment of their in vitro antimicrobial, antioxidant and cytotoxicity activities. Spectrochim. Acta Mol. Biomol. Spectrosc. 2015, 151, 939–944. [Google Scholar] [CrossRef] [PubMed]
  26. Kozissnik, B.; Bohorquez, A.C.; Dobson, J.; Rinaldi, C. Magnetic fluid hyperthermia: Advances, challenges, and opportunity. Int. J. Hyperth. 2013, 29, 706–714. [Google Scholar] [CrossRef] [PubMed]
  27. Krishnan, K. Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans. Magn. 2010, 46, 2523–2558. [Google Scholar] [CrossRef] [PubMed]
  28. Hussain, S.M.; Javorina, A.K.; Schrand, A.M.; Duhart, H.M.; Ali, S.F.; Schlager, J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 2006, 92, 456–463. [Google Scholar] [CrossRef] [PubMed]
  29. Kanagesan, S.; Hashim, M.; Tamilselvan, S.; Alitheen, N.B.; Ismail, I.; Ismail, M.A.N.; Bahmanrokh, G.; Rahman, M. Characteristics and Cytotoxicity of Magnetic Nanoparticles ON Breast Cancer Cells. J. Optoelectron. Biomed. Mater. 2014, 6, 41–50. [Google Scholar]
  30. Kanagesan, S.; Hashim, M.; Tamilselvan, S.; Alitheen, N.B.; Ismail, I.; Bahmanrokh, G. Cytotoxic Effect of Nanocrystalline MgFe2O4 Particles for Cancer Cure. J. Nanomater. 2013, 2013. [Google Scholar] [CrossRef]
  31. Yasir Rafiquea, M.; Pan, L.-Q.; Qurat-ul-ain, J.; Zubair Iqbal, M.; Qiu, H.-M.; Hassan Farooq, M.; Guo, Z.-G.; Tanveer, M. Growth of monodisperse nanospheres of MnFe2O4 with enhanced magnetic and optical properties. Chin. Phys. B 2013, 22. [Google Scholar] [CrossRef]
  32. Deraz, N.M.; Alarifi, A. Controlled Synthesis, Physicochemical and Magnetic Properties of Nano-Crystalline Mn Ferrite System. Int. J. Electrochem. Sci. 2012, 7, 5534–5543. [Google Scholar]
  33. Hilary, A.N.; Arthi, K.; Yan, G.; Ning, F.; Vellareddy, A.; Anumantha, G.K. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicol. Appl. Pharm. 2011, 256, 227–240. [Google Scholar]
  34. Elmore, S. Apoptosis: A Review of Programmed Cell Death. Toxicol. Pathol. 2007, 35, 495–516. [Google Scholar]
  35. Ella, B.W.; Douglas, R.G. Detection of Apoptosis by Annexin V Labeling. Methods Enzymol. 2000, 322, 15–18. [Google Scholar]
  36. Park, E.J.; Yi, J.; Kim, Y.; Choi, K.; Park, K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol. In Vitro 2010, 24, 872–878. [Google Scholar] [CrossRef] [PubMed]
  37. Renehan, A.G.; Booth, C.; Potten, C.S. What is apoptosis, and why is it important. Br. Med. J. 2001, 322, 1536–1538. [Google Scholar] [CrossRef]
  38. Swamy, M.K.; Sudipta, K.M.; Jayanta, K.; Balasubramanya, S. The green synthesis, characterization, and evaluation of the biological activities of silver nanoparticles synthesized from Leptadenia reticulata leaf extract. Appl. Nanosci. 2015, 5, 73–81. [Google Scholar] [CrossRef]
  • Sample Availability: Not available.
Figure 1. FT-IR spectra of manganese ferrite nano powder.
Figure 1. FT-IR spectra of manganese ferrite nano powder.
Molecules 21 00312 g001
Figure 2. XRD pattern of manganese ferrite powder calcined at 150 °C for 24 h.
Figure 2. XRD pattern of manganese ferrite powder calcined at 150 °C for 24 h.
Molecules 21 00312 g002
Figure 3. TEM image of calcined powder (a) and the corresponding particle size histogram (b).
Figure 3. TEM image of calcined powder (a) and the corresponding particle size histogram (b).
Molecules 21 00312 g003
Figure 4. Hysteresis curve of manganese ferrite sample at room temperature.
Figure 4. Hysteresis curve of manganese ferrite sample at room temperature.
Molecules 21 00312 g004
Figure 5. Growth inhibition of 4T1 murine breast cancer cells exposed to synthesized MnFe2O4 nanoparticles for 24, 48 and 72 h in cytotoxicity study using MTT assay.
Figure 5. Growth inhibition of 4T1 murine breast cancer cells exposed to synthesized MnFe2O4 nanoparticles for 24, 48 and 72 h in cytotoxicity study using MTT assay.
Molecules 21 00312 g005
Figure 6. Flow cytometry analysis of untreated and treated 4T1 cells with MnFe2O4 nanoparticles for 24 h (A); 48 h (B) and 72 h (C) stained with acridine orange and propidium iodide (AO/PI).
Figure 6. Flow cytometry analysis of untreated and treated 4T1 cells with MnFe2O4 nanoparticles for 24 h (A); 48 h (B) and 72 h (C) stained with acridine orange and propidium iodide (AO/PI).
Molecules 21 00312 g006
Figure 7. Flow cytometry analysis of untreated and treated 4T1 cells with MnFe2O4 nanoparticles for 24 h (A); 48 h (B) and 72 h (C) stained with annexin V-FITC/propidium iodide (PI).
Figure 7. Flow cytometry analysis of untreated and treated 4T1 cells with MnFe2O4 nanoparticles for 24 h (A); 48 h (B) and 72 h (C) stained with annexin V-FITC/propidium iodide (PI).
Molecules 21 00312 g007

Share and Cite

MDPI and ACS Style

Kanagesan, S.; Aziz, S.B.A.; Hashim, M.; Ismail, I.; Tamilselvan, S.; Alitheen, N.B.B.M.; Swamy, M.K.; Purna Chandra Rao, B. Synthesis, Characterization and in Vitro Evaluation of Manganese Ferrite (MnFe2O4) Nanoparticles for Their Biocompatibility with Murine Breast Cancer Cells (4T1). Molecules 2016, 21, 312. https://doi.org/10.3390/molecules21030312

AMA Style

Kanagesan S, Aziz SBA, Hashim M, Ismail I, Tamilselvan S, Alitheen NBBM, Swamy MK, Purna Chandra Rao B. Synthesis, Characterization and in Vitro Evaluation of Manganese Ferrite (MnFe2O4) Nanoparticles for Their Biocompatibility with Murine Breast Cancer Cells (4T1). Molecules. 2016; 21(3):312. https://doi.org/10.3390/molecules21030312

Chicago/Turabian Style

Kanagesan, Samikannu, Sidek Bin Ab Aziz, Mansor Hashim, Ismayadi Ismail, Subramani Tamilselvan, Noorjahan Banu Binti Mohammed Alitheen, Mallappa Kumara Swamy, and Bandaru Purna Chandra Rao. 2016. "Synthesis, Characterization and in Vitro Evaluation of Manganese Ferrite (MnFe2O4) Nanoparticles for Their Biocompatibility with Murine Breast Cancer Cells (4T1)" Molecules 21, no. 3: 312. https://doi.org/10.3390/molecules21030312

Article Metrics

Back to TopTop